
Cure51
Cure51
Claim
Cure51's proprietary data collection system, based on long-term partnerships, enables the creation of a single multimodal and multi-omics database of Outliers. Using its proprietary discovery platform powered by computational modeling, Cure51 aims to understand the biological mechanisms responsible for this exceptional survival by identifying and validating targets that can act on these interactions, leading to first-order treatments. Cure51's proprietary data collection system, based on long-term partnerships, enables the creation o Show More
Alpha Score
$ 16.37 M
Alpha Score
57.5
Predictions
Overview
Team
Financials
- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0